TTNP

Titan Pharmaceuticals
TTNP

Overview Fund Trends Analyst Outlook
Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

18 hedge funds and large institutions have $498K invested in Titan Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$28.9K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$11.2K
3
TSS
Two Sigma Securities
New York
+$9.34K
4
Renaissance Technologies
Renaissance Technologies
New York
+$47
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$46

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$19.2K
2
Group One Trading
Group One Trading
Illinois
-$45
3
WIM
Westside Investment Management
California
-$3
4
NFSG
Newbridge Financial Services Group
Florida
-$1
5
CIA
Cape Investment Advisory
Georgia
-$1
Name Holding Trade Value Shares
Change 		Shares
Change %
CIA
26
Cape Investment Advisory
Georgia
– -$1 – –
DJSG
27
D.J. St. Germain
Massachusetts
– -$1 – –
1
2